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Fibroblasts play a critical role in inflammatory reactions and wound healing 
by synthesizing new connective tissue substances (collagen and mucopolysac- 
charides)  and  constructing scar  tissue.  However,  the  mechanisms by  which 
fibroblasts are attracted to sites of inflammation are unknown. 
In the present report  we describe  a  quantitative technique that  measures 
fibroblast chemotaxis in vitro in modified Boyden chambers. While other work- 
ers have demonstrated that fibroblasts are capable of migrating in vitro and in 
vivo (1-4),  this is the first description of a  quantitative assay that measures 
fibroblast chemotactic response. 
Using  this  assay  we  have  found that  human  lymphocytes stimulated by 
specific antigen or nonspecific mitogen in vitro produce a heat stable proteina- 
ceous  substance  that  is  chemotactic for  fibroblasts.  This  substance  will  be 
referred to as "lymphocyte-derived chemotactic factor for fibroblasts" (LDCF- 
F).~ LDCF-F is distinguishable from human "lymphocyte-derived chemotactic 
factor for monocytes" (LDCF-M). 
Materials and Methods 
Fibroblast  Chemotaxis  Assay.  Dermal fibroblasts obtained from punch biopsy of the skin of 
normal adults were grown in monolayer culture by standard techniques.  Cultures  were main- 
tained in 32  oz.  Brockway  bottles  (Brockway  Glass  Co.,  Inc.  Brockway,  Pa.)  in  a  humidified 
atmosphere containing 5% CO2. Eagle's minimal essential media supplemented with nonessential 
amino acids, ascorbic acid (50 ~g/ml), NaHCO3,  and HEPES buffers (pH 7.2), penicillin (100 U/ 
ml), streptomycin (100 ~g/ml),  and heat-inactivated fetal calf serum (15%)  was used as mainte- 
nance media. A major portion of the cells in each bottle was harvested every 3-5 days for use in the 
chemotaxis assay. 
Fibroblasts  were  dispersed  routinely  by  pouring  off the  maintenance  media,  washing  the 
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J  Abbrevmtions  used  ~n this paper:  CTX, chemotactic activity; GGBS, 0.015 M  glycylglycine/ 
0.14 M  NaC1, pH 7.2;  [3H]TdR, tritiated thymidine; LBTI, lima bean trypsin inhibitor; LDCF-F, 
lymphocyte-derived chemotactic factor for fibroblasts; LDCF-M, lymphocyte-derived chemotactic 
factor for monocytes;  MNL,  mononuclear leukocyte(s);  OIF,  oil immersion field;  PBS,  0.015  M 
phosphate/0.135 M NaC1; PHA, phytohemagglutinin; PPD, purified protein derivative of tubercu- 
lin; RPMI 1640  +  PSH, RPMI 1640 media containing penicillin (100 U/ml), streptomycin (100 ~g/ 
ml) and HEPES buffer (0.001  M), pH 7.4; SKSD,  streptokinase-streptodornase. 
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monolayers three times with 30-40 ml of 0.015 M phosphate/0.135 M NaCl (PBS), pH 7.4, and by 
then adding  1.5  ml trypsin  (0.25%)  in PBS.  During trypsinization each bottle was  frequently 
agitated to facilitate detachment of the cells. Fibroblasts were exposed to trypsin for up to 3 min. 
Trypsin was inactivated by adding 10 ml maintenance media containing serum.  Detached cells 
were collected from the Brockway bottles, centrifuged at 4°C at 300 g  for 10 min, and washed two 
times with serum-free maintenance media. Fibroblasts were suspended at a concentration of 2.5 × 
105 cells/m] of serum-free media at 4°C before being used in the assay. 
Blind-well-modified Boyden chemotaxis chambers (Duke University Surgical Instrument Shop, 
Durham, N. C.) and polycarbonate filters, 13-mm diameter, containing 8-~m pores (Wallabs Inc., 
San  Rafeal,  Calif.)  were  used  to  measure  fibroblast chemotaxis.  The polycarbonate filters as 
obtained from the manufacturer were not suitable for use in the assay because fibroblasts would 
not adhere to and spread-out on the upper surface of the filters or migrate through the filter pores 
in response to a  chemotactic stimulus  (Fig.  1).  We found that fibroblasts would adhere to and 
migrate through filters previously treated with a dilute gelatin solution so as to change the surface 
properties of the filters (Fig. 2). Therefore, filters used in all experiments were treated as follows: 
filters were placed in wire staining baskets (Duke University Surgical Instrument Shop), heated 
at 50°C in 0.5% acetic acid solution for 20 min, rinsed two times in glass-distilled water at 25°C, 
placed in a  beaker containing gelatin in glass-distilled water (5 mg/liter) at 100°C for 1 h, dried 
with a  hair dryer, and heated in an oven (100°C)  for 1 h. 
Substances being assayed for fibroblast chemotactic activity (CTX) were mixed with serum-free 
maintenance media (0.4 ml/0.35 ml). Aliquots of this mixture were placed in the lower compart- 
ment of blind-well chemotaxis chambers. Prepared polycarbonate filters (dull side up) were placed 
in the chambers so as to cover the filled lower compartment,  and chamber caps containing the 
upper  compartment  were  screwed  into  the  chambers  to  effect  a  water  tight seal  around  the 
periphery of the filter. The upper chamber compartments were then loaded with the fibroblast 
suspension, prepared as described above. 
Loaded chambers were incubated at 37°C for 150 rain in a humidified atmosphere containing 5% 
CO2. After the incubation period, chambers were disassembled, filters removed, placed in staining 
baskets, fixed for 15 s in absolute ethanol, stained with hematoxylin, and mounted on glass cover 
slips. During incubation, fibroblasts responding to a chemotactic stimulus migrate from the upper 
filter surface through the pores and adhere to the lower filter surface (Fig. 2). Fibroblast CTX was 
quantitated by counting nuclei of fibroblasts on the lower surface of the filters in 20 oil immersion 
fields (×  1,000).  All samples were assayed in triplicate,  and final activity was expressed as the 
mean -+ SEM of the replicates. 
Monocyte Chemotaxis Assay.  Monocyte chemotactic activity was assayed in certain samples 
by methods previously described (5).  CTX was quantitated by determining the number of mono- 
cytes migrating per oil immersion field (×  1,000)  after counting 20 fields. 
Lymphocyte Cultures.  Peripheral blood  mononuclear leukocytes  (MNL)  were  isolated from 
venous  blood  of normal  human  donors  by  the  Ficoll-Hypaque  technique.  Isolated  MNL  were 
washed three times in RPMI 1640 media containing penicillin (100 U/ml), streptomycin (100 ftg/ 
ml),  and  HEPES  buffer  (0.01  M),  pH  7.4  (PSH)  at  4°C.  Culture  studies  designed to  measure 
production of LDCF-F were performed with MNL at a  concentration of 6  x  106 cells/ml of RPMI 
1640  +  PSH  and 5% AB+  heat-inactivated (56°C  for 30 rain) serum.  Serum was  omitted from 
cultures used to generate LDCF-F for gel filtration studies. Streptokinase-streptodornase (SKSD), 
100 U/ml (American Cyanamid Co., Lederle Laboratories Div., Pearl River, N.  Y.) and purified 
protein derivative of tuberculin (PPD),  100 ~g/ml (Ministry of Agriculture, Fisheries, and Food, 
Surrey, England) were used as stimulating antigens. Phytohemagglutinin (PHA), 1 /~g/ml (Bur- 
roughs-Wellcome, Research Triangle Park, N. C.) was used as a mitogen. Controls for each study 
consisted of antigen or mitogen added to  harvested supernates from culture  of nonstimulated 
lymphocytes. 
Lymphocyte transformation was measured by culturing MNL at a concentration of I  ×  106 cells/ 
ml RPMI  1640  +  PSH  containing 10%  AB+  heat-inactivated human serum  with and without 
antigen or mitogen. Four aliquots (0.2 ml) from each sample were placed in fiat bottom wells of 
microtiter tissue culture plates (Linbro Plastic Co., Hamden,  Conn.). Cultures were pulsed 20 h 
before harvest with 0.5 ~tCi tritiated thymidine ([3H]TdR, New England Nuclear, Boston, Mass.) 
in 0.01 ml of media.  Cells from all microcultures were harvested onto glass fiber filters (Reeve 
Angel Corp.,  Clifton, N. J.) with a  multiple sample harvester (MASH III; Microbiological Asso- 1190  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIBROBLASTS 
FIG.  1.  The  upper  photograph  is  a  low  power  view  (x  8)  of the  upper  surface  of an 
untreated polycarbonate filter taken from a  chemotaxis chamber after incubation for 150 
min with an aliquot of supernate from 96-h culture of PHA-stimulated lymphocytes  (see 
Materials and Methods). There is poor adherence of fibroblasts to the upper surface.  The 
lower photograph is a  view of the lower surface of the same filter (x  1,000).  There is no 
fibroblast migration to the LDCF-F-rich supernate. The blurred images in the background 
represent fibroblasts on the upper surface of the filter. 
ciates, Bethesda, Md.) followed by precipitation of incorporated label with 5% cold trichloroacetic 
acid (TCA). 
Glass fiber filter disks containing TCA-precipitated material were placed in vials containing 5 
ml Aquasol (New England Nuclear) and chilled at 4°C for 4 h. The radioactivity of each disk was 
measured in a Nuclear-Chicago liquid scintillation counter (Nuclear-Chicago Corp., Des Plaines, 
Ill.). All lymphocyte cultures were incubated in a  humidified atmosphere containing 5% CO2 for 
specified lengths of time. 
Gel Filtration Studies.  Columns 2.5 cm in diameter and  100 cm in length containing either 
Sephadex G-100 or Sephadex G-75 superfine (Pharmacia Fine Chemicals, Inc., Piscataway, N. J.) 
and equilibrated with 0.015  M  glycylglycine/0.14 M  NaC1  (GGBS) at pH  7.2 were  employed to 
isolate  LDCF-F  and  LDCF-M  from  lyophilized lymphocyte culture  supernates.  All lyophilized 
supernates were dissolved in 3 ml GGBS and cleared of insoluble material by centrifugation before 
being loaded  on  the  columns.  Gel  filtration was  performed  at  4°C.  The  column  effluent  was 
continuously monitored for absorbance at 280 nm with a  Uvicord III recording spectrophotometer 
(LKB  Instruments,  Inc.,  Rockville,  Md.).  Columns  were  calibrated  with  proteins  of known 
molecular weight, and a drop of tritiated water was mixed with each sample to serve as an internal 
marker for column volume. 
Heat Treatment of LDCF-F.  Heat stability of LDCF-F was evaluated by heating an aliquot of A.  E.  POSTLETHWAITE~  R.  SNYDERMAN,  AND  A.  H.  KANG  1191 
an active Sephadex fraction to 56°C  for 30 min and assaying heated and unheated aliquots for 
fibroblast CTX. 
Trypsin Treatment of LDCF-F.  To determine whether LDCF-F was susceptible to proteolytic 
digestion by trypsin, a 0.3-ml aliquot of a Sephadex fraction containing fibroblast CTX was added 
to trypsin (0.06 ~g) (Sigma Chemical Co., St. Louis, Mo.), and the mixture was incubated at 37°C 
for 2 h. Lima bean trypsin inhibitor (LBTI) (2.7 ~g) (Worthington Biochemical Corp., Freehold, 
N. J.) was added to inactivate trypsin after the 2:h incubation. As controls~ aliquots of the Sepha- 
dex fraction with fibroblast CTX were incubated for 2 h with LBTI alone andwith LBTI to which 
trypsin was added.  Fibroblast CTX was then determined in all samples. 
Neuraminidase Treatment of  LDCF°F.  In an attempt to determine whether an intact glycopro- 
tein structure was essential for retention of the biological activity of LDCF-F, an active Sephadex 
fraction was treated with Vibrio cholera neuraminidase (Worthington Biochemical Corp.). Neura- 
minidase (0.6 and 6.0 ~g) with 0.3-ml aliquots of buffer or active Sephadex fraction at pH 5 were 
incubated for 30 min at 37°C and then heated to 56°C for 30 min to partially inactivate the enzyme. 
The pH was then adjusted to 7.4,  and all samples were assayed for fibroblast CTX. This enzyme 
preparation caused release of sialic acid from bovine maxillary mucin (Worthington Biochemical 
Corp.) in a  preliminary experiment. 
Role of Macrophage in LDCF-F Production.  Since it has been demonstrated that macrophages 
are required for lymphocyte production of some lymphokines (6, 7), it was of interest to determine 
their role in LDCF-F production.  MNL were prepared by Ficoll-Hypaque  separation of venous 
blood  obtained  from  a  healthy  donor.  This  population  of  cells  contained  24%  monocytes  as 
determined by  nonspecific esterase  staining  (8).  A  population  of highly  purified  lymphocytes 
containing approximately 1% monocytes was prepared by placing the MNL in glass Petri dishes 
for 2 h and passing the nonadherent cells through a glass bead column as previously described by 
Horton et al. (7). A portion of the purified lymphocytes was mixed with fresh sheep erythrocytes to 
allow spontaneous rosettes to form (9). The rosetted and nonrosetted cells were separated from each 
other by isopyknic centrifugation on a  Ficoll-Hypaque gradient (10). The denser rosetted cells (T 
lymphocytes) were collected from the pellet on the bottom of the centrifuge tube and were washed 
five times with RPMI  1640  +  PSH.  Less than 2% of this population of cells exhibited positive 
immunofluorescent staining with polyvalent rabbit anti-human immunoglobulin antisera,  and 
only 0.6% exhibited staining for nonspecific esterase. 
Autologous macrophages were prepared by the method described by Horton et al.  (7).  86% of 
these cells stained positively for nonspecific esterase. The macrophage population was irradiated 
with 2,500 rads to kill contaminating lymphocytes and suspended in RPMI 1640 +  PSH containing 
20% AB+  serum at a  concentration of 6  x  104 cells/ml.  Aliquots (1 ml) were added to wells of 
Falcon 3008 multiwell tissue culture plates (Falcon Plastics, Div. of BioQuest, Oxnard, Calif.) and 
incubated in a humidified atmosphere containing 5% CO2 for 18 h to allow macrophages to attach 
to the plastic surfaces. The macrophage monolayers were then washed three times with RPMI 1640 
+  PSH to remove serum. 
MNL, purified lymphocyte, and T-lymphocyte populations were each separately suspended in 
RPMI 1640  +  PSH containing 5% heat-inactivated AB+ serum at a concentration of 4  ×  l0  s cells/ 
ml. Aliquots (1 ml) of each population were separately placed in wells of Falcon 3008 tissue culture 
plates and cultured with or without PHA (1.0 ~g). Aliquots (1 ml) of purified lymphocytes and T 
lymphocytes  were  separately  cultured  with  the  macrophage  monolayers  with  or  without  the 
addition of PHA. Supernates from all cultures were harvested after 48 h and were cleared of debris 
by centrifugation. As a  control, PHA (1.0 ~g) was added to supernates harvested from unstimu- 
lated cultures. All supernates were then assayed for fibroblast CTX. 
Results 
Lymphocyte  Transformation  and  Fibroblast  Chemotactic  Factor  Produc- 
tion.  The  amount  of fibroblast CTX detectable in supernates  of SKSD- and 
PHA-stimulated lymphocyte cultures at a  given time was correlated with the 
degree  of [3H]TdR incorporation  (Fig.  3).  PHA-stimulated  cultures  exhibited 
maximal  fibroblast CTX and  [3H]TdR incorporation at 72 h.  SKSD-stimulated 
cultures  contained  maximal  fibroblast CTX at  96 h,  and this  correlated with 
peak [3H]TdR incorporation. F
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FIG. 3.  Lymphocytes were cultured from a donor having a positive  delayed skin test  to 
SKSD. CTX for  fibroblasts  (upper  panel)  and  lymphocyte  transformation (lower  panel)  were 
measured in  control,  PHA- (1/~g/ml),  and SKSD-stimulated (100  U/ml)  cultures.  Cultures 
were harvested  daily  on  four  successive  days.  Production of  LDCF-F was synchronous  with 
[3H]TdR incorporation. 
Gel Filtration Studies.  Gel filtration  of  lyophilized  supernate from a culture 
of  SKSD-stimulated lymphocytes from a SKSD  skin test-positive  donor yielded a 
single  peak of  fibroblast  CTX that eluted from the Sephadex G-100 column after 
excluded proteins (Fig.  4). Supernate from nonstimulated lymphocytes from the 
same donor, to which SKSD  was added after culture, when subjected to gel 
filtration on the same  column did not yield active fractions. The tool wt of 
LDCF-F as determined by gel  filtration  on G-100 is  approximately 22,000 daltons 
(Fig. 5). 
Additional studies revealed that LDCF-F  was clearly distinguishable  from 
LDCF-M.  When  concentrated  supernate  from  a  culture of PHA-stimulated 
lymphocytes  was  subjected  to gel filtration on a  2.5  x  100  cm  column  of 
Sephadex G-75 superfine, a discrete peak of fibroblast CTX eluted in advance of 
the monocyte CTX peak (Fig.  6). 
Physicochemical Characterization of LDCF-F.  Physicochemical studies were 
performed on partially purified LDCF-F isolated by Sephadex G-100 chromatog- 
raphy.  LDCF-F  was  found to be heat  stable  since  its  biological  activity  was 
unchanged after incubation at 56°C for 30 min (Table I). 
LDCF-F is protein in nature, being susceptible to digestion by trypsin (Table 
II).  LBTI used to inactivate  trypsin after its incubation with LDCF-F did not 
effect the fibroblasts' chemotactic response to LDCF-F, and it was not chemotac- 1194  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIEROBLASTS 
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FIG.  4.  MNL  (4  x  l0  s cells/ml)  from a  donor with a  positive  delayed skin test to SKSD 
were cultured in serum-free RPMI 1640  +  PSH for 72 h. To one-half of the cells SKSD (100 
U/ml) was added before culture,  and to the other half SKSD was added to the supernate 
after harvest at 72 h. Culture supernates were lyophilized, and 30 mg of each was dissolved 
in  GGBS  (3  ml)  and  chromatographed  at  different  times  on  the  same  Sephadex  G-100 
column (2.5  x  100 cm).  Fractions  (4.9 ml) were collected from each column run and were 
assayed on different days'for fibroblast CTX (see Materials and Methods). A single peak of 
fibroblast  CTX  was found in fractions from gel  filtration  of SKSD-stimulated supernate 
(upper panel).  No CTX was found in fractions from gel filtration of control supernate.  A 
positive control (0.35 ml unfractionated SKSD-stimulated supernate) was included in each 
chemotaxis experiment.  Fibroblast CTX for the control was 63  +- 5 on the day "stimulated 
SKSD"  fractions  were  assayed  and  57  _+  6  on  the  day  "control-SKSD"  fractions  were 
assayed. 
tic itself (Table II). The biological activity of LDCF-F does not appear to depend 
on a  glycopeptide structure involving sialic acid, since it retained its activity 
after neuraminidase treatment (Table III). 
Effect of LDCF-F on Fibroblast Migration.  It was essential to determine 
whether the fibroblasts were recognizing the  lymphocyte-derived factor as  a 
chemotactic stimulus or as a stimulator of random cell migration. To determine 
which was the case, we compared migration of fibroblasts through the chamber 
filters in the presence and absence of a concentration gradient of LDCF-F (Fig. 
7).  When LDCF-F was placed in equal concentration in the upper and lower 
compartments  of  the  modified  Boyden  chamber,  migration  of  fibroblasts 
through the filter was the same as when buffer was  added in equal concentration 
to both compartments (Fig. 7), suggesting that random migration of  the cell was 
not stimulated by the lymphocyte-derived factor.. In contrast, fibroblasts mi- 
grated through the chamber filters in numbers greater than that observed in A.  E.  POSTLETHWAITE,  R.  SNYDERMAN,  AND  A.  H.  KANG  1195 
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chambers having the buffer control only when LDCF-F was added exclusively to 
the  lower test compartment  (Fig.  7),  suggesting  that  it  stimulates  fibroblast 
migration by acting as a  chemotactic stimulus. 
Macrophage Dependence for LDCF-F Production.  Culture studies revealed 
that lymphocytes stimulated  with PHA required the presence of macrophages 
for  production  of LDCF-F.  Unfractionated  MNL  containing  24%  monocytes 
elaborated fibroblast chemotactic factor in response to PHA stimulation  (Table 
IV). However, when lymphocytes were purified from MNL they did not produce 
chemotactic factor unless macrophages were added to the culture (Table IV). In 1196  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIBROI~LASTS 
TABLE  I 
Effect of Heat on Chemotactic Activity of LDCF-F 
Chemotactic activity  Substance tested*  Incubation 
(mean ± SEM) 
fibroblasts per 20 OIF 
LDCF-F  56°C-30 mAn  54  _+ 6 
Column effluent  56°C-30 mAn  5 _+ 1 
LDCF-F  -  48 ±  5 
Column effluent  -  3 _+ 1 
* Aliquots (0.3 ml) of a LDCF-F-rich Sephadex G-100 fraction or of column effluent 
were tested for fibroblast CTX with and without being heated to 56°C for 30 mAn. 
TABLE  II 
Effect of Trypsin on Chemotactic Activity of LDCF-F 
Substances added 
Before incubation*  After incubation* 
Chemotactic activ- 
ity (mean +- SEM) 
fibroblasts  per  20 
OIF 
LDCF$  GGBS-CaCl~ (50 tel)§  42  __ 6 
LDCF-F + trypsi~l (25 tel)  LBTI¶ (25 tel)  5 ±  1 
LDCF-F + LBTI (25 tel)  Trypsin (25 ~tl)  37  -* 3 
LDCF-F + LBTI (25 /~l)  GGBS-CaCI2 (25 ~l)  41  ±  5 
Column effluent§  GGBS-CaCl~ (50 /~1)  4 ±  1 
* Incubations were at 37°C for 2 h. 
$ Aliquots (0.3 ml) of a LDCF-F-rich column fraction or of column effluent collected before the 
excluded volume from a Sephadex G-100 column. 
§ GGBS supplemented with 0.005 M CaCl2. 
II Trypsin (0.06 teg in 25 tL1 of GGBS-CaC12) was added as indicated. 
¶ LBTI (2.7 t~g in 25 tel of GGBS-CaCI~) was added as noted. 
like manner,  T  lymphocytes did not produce chemotactic factor unless cultures 
were supplemented  with macrophages  (Table IV). 
Fibroblast Chemotactic Factor Production  and Skin  Test Positivity.  In an 
effort to  investigate  the  correlation between  delayed  dermal  hypersensitivity 
and production of LDCF-F,  CTX  for fibroblasts was determined  in supernates 
from  cultures  of lymphocytes  from  four  PPD  skin test-positive and  four  PPD 
skin test-negative healthy volunteers (Table V). PPD-positive subjects produced 
fibroblast chemotactic factor when their MNL were cultured with PPD,  mean  _+ 
SEM  CTX  for PPD  control  and  stimulated  cultures being  13  _+  1  and  60  _  4, 
respectively.  In  contrast,  PPD-negative  subjects  did not  produce  chemotactic 
factor when their lymphocytes were cultured with PPD,  mean  _  SEM  CTX for 
control and stimulated  cultures being 15  _+  1 and  17  +  2, respectively. Produc- 
tion of LDCF-F by MNL after PHA stimulation was similar in PPD-positive and 
PPD-negative  groups, mean  _  SEM CTX being 66  _  7 and 57  _+ 5, respectively. 
Mean  fibroblast  CTX  in  supernates  of PHA  control  cultures  was  13  +_  2  in 
tuberculin-positive and  15  _  1 in tuberculin-negative  subjects. 
Chemotactic  Response  of Different  Fibroblast Lines.  Six  different  human 
dermal fibroblast lines were tested for their ability to respond to aliquots of the A.  E.  POSTLETHWAITE,  R.  SNYDERMAN,  AND  A.  H.  KANG 
TABLE  III 
Effect of Neuraminidase on CTX of LDCF-F 
1197 
Condition*  Chemotactic activity 
(mean _+ SEM) 
LDCF-F + GGBS  (25 /~l) 
LDCF-F + neuraminidase (0.6  /~g/25  ~l GGBS) 
LDCF-F + neuraminidase (6 ~g/25/~l GGBS) 
Column effluent  + neuraminidase (0.6  pg/25 /~I  GGBS) 
Column effluent  + neuraminidase (6/~g/25  /~l  GGBS) 
Column effluent  + GGBS  (25/~I) 
fibroblasts per 20 OIF 
37_+4 
42_+6 
44_+5 
4_+1 
4_+1 
3_+1 
* LDCF-F-rich Sephadex fraction or column effluent (0.3-ml aliquots of each) were incubated with 
or without neuraminidase  at pH 5.0, 37°C for 30 min and at 56°C for 30 min. The pH was then 
adjusted to 7.4 and samples were assayed for chemotactic activity. 
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FIo. 7.  LDCF-F-rich fraction  or  column buffer  were added in  equal amounts to  the upper 
and, or lower compartments of modified Boyden chemotaxis chambers as illustrated. 
Fibroblast  migration  through chamber filters  occurred only when a concentration  gradient 
existed  across  the filters  by placing LDCF-F exclusively  in the lower chamber compart- 
ment, 
same supernates from PHA-stimulated and control lymphocyte cultures. Migra- 
tion to control culture supernate ranged from 12 to 23 cells per 20 oil immersion 
fields (OIF) (Table VI). Migration of fibroblasts to supernate from PHA-stimu- 
lated  lymphocyte culture  ranged  from  61  to  95  cells  per  20  OIF  (Table  IV). 
Fibroblast  migration  to  PHA-stimulated  culture  supernate  was  statistically 
different  from  migration  to  control  supernate  when  analyzed  by  the  paired 
Student's t test (P <  0.0005). These data suggest that the chemotactic attraction 
of dermal  fibroblasts  to  LDCF-F is  probably an  inherent  property  of dermal 
fibroblasts of all normal individuals. 
Chemotactic  Response  of Fibroblasts  Dispersed  with EDTA.  The  use  of 
trypsin to disperse cells from monolayer cultures raised the question of altera- 1198  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIBROBLASTS 
TABLE  IV 
Macrophage Dependence for LDCF-F Production  by Lymphocytes 
Culture*  Chemotactic activity* (mean ±  SEM) 
fibroblasts per 20 OIF 
Mononuclear leukocytes 
Control  12  ±  2 
PHA  44  ±  5 
With macrophages  Without macrophages 
Purified lymphocytes 
Control  20  ±  3  3  -+  1 
PHA  82  +_  12  6  ±  1 
T  lymphocytes 
Control  14  ~- 2  2  ±  3 
PHA  65  _~ 7  1  ±  1 
Media 
Control  11  ±  1  4  _+  1 
PHA  10  ±  2  5  -+ 2 
* MNL,  purified  lymphocytes, T  lymphocytes, and  media were  cultured  with  and 
without PHA (1 ~g/ml). Macrophages were cultured with purified lymphocytes, T 
lymphocytes, and media as noted.  See Materials and Methods for details. 
$ Culture supernates were harvested after 48 h  and assayed for fibroblast CTX. 
TABLE  V 
LDCF-F Production  by Tuberculin-Positive and -Negative Subjects* 
Condition 
Chemotactic activity (mean ±  SEM) 
Control  PPD 
fibroblasts for 20 OIF 
Tuberculin-positive subject 
1  10±  2  60+_9 
2  16  ±2  65  -+8 
3  12  ±  3  49  ±  4 
4  14  ±  1  65  ±  7 
Mean ±  SEM  13  ±  1  60  ±  4 
Tuberculin-negative subject 
5  15  ±  2  19  ±  1 
6  13  ±  1  17  ±  2 
7  16  ±  3  20  ±  3 
8  14 ___  1  13  ±  3 
Mean ±  SEM  15  _+  1  17  ±  2 
* Peripheral blood MNL were obtained from tuberculin-positive and -negative sub- 
jects and cultured as described in Materials and Methods for 4 days with or without 
PPD  (10  ~g/ml)  and  PHA  (1  ~g/ml).  As controls,  cells  from  each  subject were 
cultured  with  media  alone,  and  PPD  and  PHA  were  each  added  separately  to 
harvested supernates. PHA induced production of LDCF-F to a  similar degree in 
tuberculin-positive  and  -negative  individuals,  CTX  being  66  _+  7  and  57  _+  5, 
respectively. Mean CTX in PHA control cultures of tuberculin-positive and -nega- 
tive subjects was 13  ±  2 and 15  ±  1, respectively. A.  E.  POSTLETHWAITE,  R.  SNYDERMAN,  AND  A.  H.  KANG 
TABLE  VI 
Chemotactic  Response of Different Human Fibroblast Lines to 
LDCF-F* 
Fibroblast line 
Chemotactic activity (mean ±  SEM) 
Control  PHA 
fibroblasts per 20 OIF 
S-10  12  ±  2  89  ±  6 
Y-51  17_+  2  81  ±  5 
S-14  23  ±  1  72  ±  8 
S-19  16  ±  2  86  ±  8 
D-21  14  ±  1  61  ±  6 
S-21  19  ±  3  95  -+  10 
* Six different fibroblast lines were tested on the same experimental 
day to compare their responsiveness to aliquots of the same super- 
nates from culture of PHA-stimulated and control MNL from a normal 
donor (see Materials and Methods). Each culture supernate (0.15 ml) 
was mixed with 0.25 ml GGBS and 0.35 ml serum-free maintenance 
media and assayed in triplicate for fibroblast CTX. 
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tion of the fibroblast's membrane receptor for LDCF-F by the proteolytic action 
of the enzyme. Evidence accumulated from other sources has suggested that in 
some instances proteases may temporarily uncover hidden membrane receptors 
not normally  exposed and  in  effect create  a  new receptor  (11).  To determine 
whether trypsin was uncovering a membrane receptor for LDCF-F not normally 
accessible,  fibroblasts grown  in  monolayer culture  for 4  days were dispersed 
with 0.0005 M EDTA and tested for their ability to respond chemotactically to 
LDCF-F.  Fibroblasts harvested  with EDTA were able to respond  chemotacti- 
cally to  LDCF-F  in  supernates  from  culture  of PHA-  and  SKSD-stimulated 
lymphocytes or in column fractions  (Table VII). 
Effect  of Prolonged  Trypsinization  on  Fibroblast  Chemotactic  Responsive- 
ness.  The length of time that fibroblasts are exposed to trypsin during disper- 
sion from monolayer culture influences their ability to respond chemotactically 
to LDCF-F.  Fibroblasts respond well if trypsinization  is limited to 3 or 5 min 
(Table VIII).  If trypsinization  is continued  for  10 min the response is greatly 
diminished,  and if it is continued for 15 min fibroblasts do not respond chemo- 
tactically at all (Table VIII). Fibroblasts exposed to trypsin for 15 min adhered to 
the  upper  surface  of the  gelatin-treated  polycarbonate filters just  as  well  as 
those exposed for 3 or 5 min and appeared to be unaltered morphologically by 
light microscopy (data not shown). 
Discussion 
A quantitative in vitro assay that measures fibroblast chemotaxis in modified 
Boyden chambers  has been described.  By employing this  technique,  we have 
found that  human peripheral  blood lymphocytes when stimulated  by mitogen 
(PHA) or antigens (SKSD, PPD) produce a factor that is chemotactic for human 
dermal fibroblasts.  We have called this substance "lymphocyte-derived chemo- 
tactic factor for fibroblasts" or LDCF-F. 
Production of LDCF-F by lymphocytes obtained by isopyknic centrifugation of 1200  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIBROBLASTS 
TABLE  VII 
Chemotactic Response of Fibroblasts Dispersed with 0.0005 M 
EDTA * 
Chemotactic Activity 
Substance tested 
(mean _+  SEM) 
LDCF-F$ 
Buffer 
Lymphocyte supernates§ 
Stimulated-PHA 
Control-PHA 
Stimulated-SKSD 
Control-SKSD 
fibroblasts per 20 OIF 
36_+3 
5-+2 
79_+6 
13_+6 
95_+5 
14_+1 
* Fibroblasts were grown in monolayer culture for 4 days and harvested 
with 0.0005 M EDTA in PBS. Dispersed cells were washed two times 
in maintenance media and tested for their ability to respond chemo- 
tactically. 
$ LDCF-F was obtained from pooled active Sephadex fractions. 
§ Lymphocyte supernates were harvested after 96 h of culture in RPMI 
1640 media supplemented with 5% AB+ human serum (see Materials 
and Methods). 
TABLE  VIII 
Effect of Duration of Trypsinization on Fibroblast Chemotactic 
Trypsinization* 
Responsiveness 
Chemotactic activity (mean -+ SEM) 
Control  PHA 
min  fibroblasts per 20 OIF 
3  18  -+  1  88  _+  9 
5  16-+2  96_+9 
10  8 _+  1  19  _+  1 
15  10  ___  2  10  -+  1 
* Fibroblasts of the same line were grown in four Brockway bottles. 
Cells were dispersed  by 0.25% trypsin in PBS as described in Materials 
and Methods except the duration of trypsinization was different for 
each bottle, ranging from 3 to 15  min as indicated. Cells from each 
bottle were tested for their ability to  migrate  in modified Boyden 
chambers to aliquots of  the same control and PHA-stimulated lympho- 
cyte culture supernates. 
peripheral blood with Ficoll-Hypaque appears to be synchronous with mitogene- 
sis induced by antigen or mitogen stimulation. In addition, production of LDCF- 
F in the presence of PPD correlates with delayed hypersensitivity  to this antigen 
as measured by skin testing. 
Purified T lymphocytes stimulated by PHA require macrophages for produc- 
tion of LDCF-F.  Osteoclast-activating factor and interferon are two other lym- 
phokines that require macrophages for their production by lymphocytes (6, 7). 
LDCF-F from antigen- or mitogen-stimulated lymphocytes has a  mol wt of 
approximately 22,000 daltons. It is clearly distinct from LDCF-M. The findings 
that LDCF-F is not chemotactic for human monocytes, and that LDCF-M is not A.  E.  POSTLETHWAITE,  R.  SNYDERMAN,  AND  A.  H.  KANG  1201 
chemotactic for fibroblasts suggest that chemotactic receptors on monocytes and 
fibroblasts may be different.  In contrast to this  dichotomy between fibroblast 
and  monocyte receptors for lymphocyte-derived chemotactic factors,  we have 
found  that  native  collagen,  constituent  al-  and  a2-chains  of collagen  and 
peptides obtained by collagenase, cyanogen bromide, and pepsin degradation of 
collagen are chemotactic for monocytes (12) and fibroblasts. 2 Thus,  it appears 
that  similar  receptors for collagen  and collagen peptides are present  on both 
fibroblasts and monocytes. 
The  fibroblast  surface  membrane  receptor  for  LDCF-F  has  not  been  fully 
characterized, but our data suggest that it is readily accessible, being present on 
cells  dispersed  by EDTA  or  brief trypsinization.  The  finding  that  prolonged 
trypsinization  renders the fibroblast chemotactically unresponsive to LDCF-F 
could be due to removal or alteration of the receptor or to an effect of trypsin on 
other membrane proteins involved in the chemotactic response. The demonstra- 
tion that trypsin can temporarily destroy a membrane receptor has been exten- 
sively documented for the  adipose cell receptor for insulin  (13-16).  Definitive 
information  regarding  the  nature  of the  fibroblast receptor  for  LDCF-F will 
have to await its isolation and purification. 
The  finding  that  fibroblasts  are  able  to  respond  chemotactically  to  a  T- 
lymphocyte-derived factor in vitro may have significance in vivo. For example, 
cell-mediated immune reactions produced by tubercle bacilli and Schistosoma 
mansoni result in formation of granulomas that are characterized by the pres- 
ence of increased members of fibroblasts (17, 18). Perhaps the release of LDCF-F 
by sensitized,  stimulated  lymphocytes might  function  to  attract  neighboring 
connective  tissue  fibroblasts  to  these  granulomas.  The  organized  connective 
tissue capsule that  characteristically  surrounds  "benign"  tumors  may in  like 
manner  result from release  of LDCF-F by host lymphocytes as they react to 
neoplastic cells. 
Recently,  humans  with  pulmonary  fibrosis  (19)  and  progressive  systemic 
sclerosis  (20) have been found to have evidence of cell-mediated immunity  to 
collagen.  Both  of these  conditions  are  characterized  by lesions  that  contain 
increased numbers of fibroblasts and increased deposition of collagen. Perhaps T 
lymphocytes sensitized to collagen in these disease states release LDCF-F upon 
contact with collagen in vivo, and this leads to fibroblast accumulation. 
This study demonstrates that lymphocytes under appropriate stimulation by 
antigen  or mitogen  in  vitro produce a  chemotactic factor for fibroblasts.  The 
function and role of such a  chemotactic factor in vivo remain to be defined. 
Summary 
A  quantitative  assay  that  measures  fibroblast  chemotaxis  in  vitro  is  de- 
scribed.  Application  of this technique has revealed that peripheral  blood lym- 
phocytes  stimulated  by antigen  or  mitogen  in  vitro  produce a  factor that  is 
chemotactic for human dermal fibroblasts. This lymphocyte-derived chemotactic 
factor for fibroblasts (LDCF-F) is different from the lymphokine that is chemo- 
tactic for monocytes or macrophages.  Macrophages are required for the genera- 
2 Postlethwaite,  A.  E.,  and  A.  H.  Kang.  Chemotactic  attraction  of human  fibroblasts  to 
collagen and collagen derived peptides.  Manuscript submitted for publication. 1202  LYMPHOCYTE-DERIVED  CHEMOTACTIC  FACTOR  FOR  FIBROBLASTS 
tion  of LDCF-F  by  T  lymphocytes stimulated  by  phytohemagglutinin.  The 
fibroblast chemotactic factor is heat stable  (56°C  for 30 min), trypsin sensitive, 
and neuraminidase resistant.  LDCF-F could function to attact connective tissue 
fibroblasts  to sites  at which cell-mediated immune reactions are  occurring in 
vivo. 
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